Frankfurt - Delayed Quote EUR

Stryker Corporation (SYK.F)

346.40
-7.60
(-2.15%)
As of 10:04:36 AM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Kevin A. Lobo Chairman, CEO & President 4.73M 38.78M 1965
Mr. Viju S. Menon Group President of Global Quality & Operations 1.4M -- 1968
Mr. Glenn S. Boehnlein CPA Advisor 1.89M 17.76M 1962
Mr. J. Andrew Pierce Group President of MedSurg & Neurotechnology 1.68M 2.12M 1974
Mr. Spencer S. Stiles Group President of Orthopaedics & Spine 1.68M -- 1977
Mr. Preston Wells VP & CFO -- -- --
Mr. William E. Berry Jr. VP & Chief Accounting Officer -- -- 1966
Mr. Robert C. Cohen CTO and VP of Global R&D - Joint Replacement -- -- --
Mr. Alan Douville VP, Chief Information Officer & Chief Information Security Officer -- -- --
Mr. Jason Beach Vice President of Finance & Investor Relations -- -- --

Stryker Corporation

1941 Stryker Way
Portage, MI 49002
United States
(269) 385-2600 https://www.stryker.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
53,000

Description

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Corporate Governance

Stryker Corporation’s ISS Governance QualityScore as of May 1, 2025 is 5. The pillar scores are Audit: 8; Board: 7; Shareholder Rights: 6; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 30, 2025 at 12:00 AM UTC

Ex-Dividend Date

July 28, 2025 at 10:59 AM UTC - August 1, 2025 at 12:00 PM UTC

Stryker Corporation Earnings Date

Recent Events

Related Tickers